V-Card | Print | PDF | Email Page

Larissa C. Bergin


(T) +1.202.879.5499
(F) +1.202.626.1700


  • The Catholic University of America (J.D. magna cum laude 2007; Associate Editor, Law Review; Willem C. Vis International Commercial Arbitration Moot Team); Boston University (B.A. in Psychology and Sociology magna cum laude 2004)

Bar Admissions

  • District of Columbia, New York, and Connecticut


  • Law Clerk to the Honorable Francis M. Allegra, U.S. Court of Federal Claims (2007-2008) and externship with the Honorable Jacob P. Hart, U.S. District Court, Eastern District of Pennsylvania (Summer 2005)

Government Service

  • Legal intern, Federal Communications Commission, Media Bureau, Policy Division (2005-2006)

Larissa Bergin's practice addresses the antitrust concerns arising from M&A matters, joint ventures, federal investigations, and commercial practices. She has overseen the antitrust aspects of corporate M&A, including due diligence, risk-shift negotiations, Hart-Scott-Rodino (HSR) filings, Second Requests, investigational hearings, integration planning, and consent decrees with federal agencies. She works with clients in a variety of industries, including the technology, health care, retail, and pharmaceutical sectors. Many of Larissa's clients have international reach, and she has been involved in matters that require advocacy before governments throughout Asia, the EU, and North America.

Larissa also advises clients on corporate contracting and operational practices that can run afoul of the antitrust laws, including supplier agreements, information sharing, competitive benchmarking, and Robinson-Patman Act pricing matters.

At the start of her career, Larissa clerked at the U.S. Court of Federal Claims, where she addressed intellectual property, tax, and government contract issues, including Serco, Inc. v. United States (also referred to as the Alliant protest), a bid-protest case involving a $50 billion procurement for government-wide information technology and services.

Larissa is a member of the Antitrust Section of the American Bar Association and is secretary of the New York State Bar Association, Food, Drug, and Cosmetics Law Section. She is admitted in the New York, Connecticut, and District of Columbia bars.

Larissa has been quoted on MSNBC regarding how Obamacare has affected M&A activity and in Getting the Deal Through on generic drug approval.

Honors & Distinctions

  • Secretary of the Food, Drug and Cosmetic Law Section of the New York State Bar Association, which is at the forefront of addressing the current regulatory framework in light of new technologies and advancements, such as biologics
Larissa Bergin